Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: Evidence for antigen-driven intraclonal diversification

Blood

Volumn 109, Issue 4, 2007, Pages 1559-1567

  Volkheimer, Alicia D ^a   Weinberg, J Brice ^a   Beasley, Bethany E ^a   Whitesides, John F ^a   Gockerman, Jon P ^a   Moore, Joseph O ^a   Kelsoe, Garnett ^a   Goodman, Barbara K ^a   Levesque, Marc C ^b,c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN RECEPTOR;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; CELL POPULATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENEALOGY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

EID: 33846916636     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-05-020644     Document Type: Article

References (48)

1. Caligaris-Cappio F. How immunology is reshaping clinical disciplines: the example of haematology. Lancet. 2001;358:49-55.
2. Kuppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Eng J Med. 1999;341:1520-1529.
3. H gene diversification. J Exp Med. 2002;196:629-639.
4. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840-1847.
5. Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102:1515-1525.
6. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848-1854.
7. Schroeder HW Jr, Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today. 1994;15:288-294.
8. Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194:1625-1638.
9. Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194:1639-1647.
10. Damle RN, Ghiotto F, Valetto A, et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood. 2002;99:4087-4093.
11. Schettino EW, Cerutti A, Chiorazzi N, Casali P. Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis. J Immunol. 1998;160:820-830.
12. H4-34 expressing single leukemic B cells. Blood. 2002;100:3419-3422.
13. Sakai A, Marti GE, Caproaso N, et al. Analysis of expressed immunoglobulin heavy chain genes in familial B-CLL. Blood. 2000;95:1413-1419.
14. Dono M, Hashimoto S, Fais F, et al. Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification. Blood. 1996;87:1586-1594.
15. Korganow AS, Martin T, Weber JC, et al. Molecular analysis of rearranged VH genes during B cell chronic lymphocytic leukemia: intraclonal stability is frequent but not constant. Leuk Lymphoma. 1994;14:55-69.
16. Roudier J, Silverman GJ, Chen PP, Carson DA, Kipps TJ. Intraclonal diversity in the VH genes expressed by CD5-chronic lymphocytic leukemia-producing pathologic IgM rheumatoid factor. J Immunol. 1990;144:1526-1530.
17. Stamatopoulos K, Kosmas C, Stavroyianni N, Loukopoulos D. Evidence for immunoglobulin heavy chain variable region gene replacement in a patient with B cell chronic lymphocytic leukemia. Leukemia. 1996;10:1551-1556.
18. Cerutti A, Zan H, Shah S, Schattner E, Schaffer A, Casali P. Ongoing in vivo class switch DNA recombination in chronic lymphocytic leukemia B cells. J Immunol. 2002;169:6594-603.
19. Bagnara D, Callea V, Stelitano C, et al. IgV gene intraclonal diversification and clonal evolution in B-cell chronic lymphocytic leukemia. Br J Haematol. 2006;133:50-58.
20. Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87:4990-4997.
21. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77-89.
22. Brezinschek HP, Brezinschek RI, Lipsky PE. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol. 1995;155:190-202.
23. Campbell MJ, Zelenetz AD, Levy S, Levy R. Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire. Mol Immunol. 1992;29:193-203.
24. Foster SJ, Brezinschek H-P, Brezinschek RI, Lipsky PE. Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells. J Clin Invest. 1997;99:1614-1627.
25. Tomlinson IM, Williams SJ, Corbett SJ, Cox JBL, Winter G. V BASE sequence directory. Vol 2002. Cambridge, United Kingdom: MRC Centre for Protein Engineering; 1996.
26. MRC Centre for Protein Engineering. V Base: database of human antibody genes. http://vbase.mrc-cpe.cam.ac.uk. Accessed April 28, 2006.
27. National Center for Biotechnology Information. IgBLAST: immunoglobulin basic local alignment search tool. http://www.ncbi.nlm.nih.gov/igblast. Accessed April 28, 2006.
28. Lossos I, Tibshirani R, Narasimhan B, Levy R. The inference of antigen selection on Ig genes. J Immunol. 2000;165:5122-5126.
29. McKean D, Huppi K, Bell M, Staudt L, Gerhard W, Weigert M. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc Natl Acad Sci U S A. 1984;81:3180-3184.
30. Sablitzky F, Wildner G, Rajewsky K. Somatic mutation and clonal expansion of B cells in an antigen-driven immune response. EMBO J. 1985;4:345-350.
31. Kleinstein SH, Louzoun Y, Shlomchik MJ. Estimating hypermutation rates from clonal tree data. J Immunol. 2003;171:4639-4649.
32. Kipps TJ, Tomhave E, Pratt LF, Duffy S, Chen PP, Carson DA. Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 1989;86:5913-5917.
33. Sthoeger ZM, Wakai M, Tse DB, et al. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med. 1989;169:255-268.
34. Borche L, Lim A, Binet JL, Dighiero G. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood. 1990;76:562-569.
35. Johnson TA, Rassenti LZ, Kipps TJ. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol. 1997;158:235-246.
36. Tobin G, Thunberg U, Johnson A, et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood. 2002;99:2262-2264.
37. Messmer BT, Albesiano E, Efremov DG, et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med. 2004;200:519-525.
38. Ghiotto F, Fais F, Valetto A, et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest. 2004;113:1008-1016.
39. Herve M, Xu K, Ng YS, et al. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest. 2005;115:1636-1643.
40. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Eng J Med. 2005;352:804-815.
41. Hamblin T. Is chronic lymphocytic leukemia a response to infectious agents? Leuk Res. 2006;30:1063-1064.
42. Capello D, Zucchetto A, Degan M, et al. Immunophenotypic characterization of IgVH3-72 B-cell chronic lymphocytic leukaemia (B-CLL). Leuk Res. 2006;30:1197-1199.
43. Robak T. Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia. Hematology. 2004;9:387-400.
44. Manusow D, Weinerman BH. Subsequent neoplasia in chronic lymphocytic leukemia. JAMA. 1975;232:267-269.
45. Hisada M, Biggar RJ, Greene MH, Fraumeni JF Jr, Travis LB. Solid tumors after chronic lymphocytic leukemia. Blood. 2001;98:1979-1981.
46. Kyasa MJ, Hazlett L, Parrish RS, Schichman SA, Zent CS. Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death. Leuk Lymphoma. 2004;45:507-513.
47. Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev Cancer. 2004;4:644-653.
48. Degan M, Bomben R, Dal Bo M, et al. Analysis of IgVH gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery. Br J Haematol. 2004;126:29-42.